|
|||||||||
|
Scientific Advisory Board |
| Dr. Michael Corey |
|
Dr. Michael Corey has fifteen years of experience in biotechnology beyond his doctoral training. His initial conception of the coupled luminescent cytotoxicity assay in the late 1990s led to an expanding array of applications, publications, and intellectual property, including the fundamental patent on one-step coupled luminescent cytotoxicity assays (US Patent #6811990). He reported an extremely rapid, ultra-sensitive phosphate/phosphatase assay at the Intelligent Drug Discovery conference in 2002 as an invited speaker, and up-to-date coupled luminescent methods were published with Dr. R. J. Kinders in Chapter 16 of the Drug Discovery Handbook (Wiley & Sons, 2005). Dr. Corey’s coupled luminescent technology is currently licensed exclusively to Cell Technology, Inc., including assays of cytotoxicity by G3PDH and LDH release, phosphate/phosphatase activity, acetylcholinesterase activity, and several methods in late-stage development. |
| Dr. Steve Sherwood, PhD |
|
Dr. Steve Sherwood has over 20 years of experience in the field of cell Biology, beyond his doctoral training. He brings a wealth of knowledge in cell based assay development, and has over 40 publications and 9 patents. He has held lead positions at Applied Biosystems, Genencor, Geron Corp, Molecular Probes, Genentech and Stanford University. |
